ABSTRACT

COVID-19 Testing Supply Chain [February 25, 2021]   [open pdf - 437KB]

From the Introduction: "COVID-19 [coronavirus disease 2019] testing--including for diagnosis, screening, and surveillance--is a critical component of responding to the COVID-19 pandemic, and its implementation has posed numerous challenges. Issues have included those related to Food and Drug Administration (FDA) regulation of tests, reimbursement and coverage for testing, equitable access to testing, and infrastructure and supply chain stressors, among others. In particular, the diagnostic testing supply chain has shown evidence of significant and ongoing stress since early in the pandemic, and problems persist with ascertainment, production, and distribution of almost all testing supply chain components."

Report Number:
CRS In Focus, IF11774
Author:
Publisher:
Date:
2021-02-25
Series:
Copyright:
Public Domain
Retrieved From:
Congressional Research Service: https://crsreports.congress.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations